Apollo Hospitals has received approval from the National Company Law Tribunal (NCLT) for its proposed composite scheme of arrangement. This strategic restructuring involves the demerger of its identified business undertaking into Apollo Healthtech Limited. The process includes the consolidation of pharmacy distribution businesses to drive digital health growth. Meetings for shareholders and creditors are scheduled for May 2026 to finalize the arrangement, marking a pivotal step in the company’s long-term growth strategy.
Strategic Business Restructuring
The National Company Law Tribunal (NCLT), Chennai Bench, has passed an order dated March 26, 2026, allowing the application for the proposed composite scheme of arrangement. This scheme involves Apollo Hospitals Enterprise Limited, Apollo Healthco Limited, Keimed Private Limited, and the newly formed Apollo Healthtech Limited. The restructuring is designed to carve out the identified healthcare services business into a dedicated entity, allowing for a more focused and agile management structure.
Rationale Behind the Scheme
The primary goal of this reorganization is to achieve operational efficiency and synergistic growth. By consolidating the pharmacy distribution business under a separate, specialized vehicle, Apollo aims to enhance its digital health offerings and streamline supply chain management. This move is expected to attract a broader base of investors, strategic partners, and lenders while promoting better administrative efficiency and internal controls across the new organizational structure.
Key Milestones and Next Steps
Following the judicial sanction, the company is now moving forward with the requisite convening of meetings for shareholders and creditors. These meetings are scheduled throughout May 2026. The process remains subject to final approval from stakeholders, as well as necessary statutory and regulatory clearances. The company intends to leverage this restructuring to improve transparency, mitigate supply chain risks, and capture economies of scale in the rapidly evolving healthcare sector.
Source: BSE
